SPDR S&P Biotech ETF (NYSEARCA:XBI) Holdings Raised by Petredis Investment Advisors LLC

Petredis Investment Advisors LLC boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.2% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 54,826 shares of the exchange traded fund’s stock after buying an additional 122 shares during the period. Petredis Investment Advisors LLC owned 0.07% of SPDR S&P Biotech ETF worth $5,417,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of XBI. Swedbank AB acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $22,843,000. Creative Planning raised its holdings in SPDR S&P Biotech ETF by 15.6% during the third quarter. Creative Planning now owns 29,114 shares of the exchange traded fund’s stock worth $2,876,000 after purchasing an additional 3,920 shares in the last quarter. Fiduciary Alliance LLC raised its holdings in SPDR S&P Biotech ETF by 2.8% during the third quarter. Fiduciary Alliance LLC now owns 23,966 shares of the exchange traded fund’s stock worth $2,368,000 after purchasing an additional 648 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in SPDR S&P Biotech ETF in the third quarter worth approximately $44,000. Finally, Shaker Investments LLC OH boosted its stake in SPDR S&P Biotech ETF by 63.5% during the 3rd quarter. Shaker Investments LLC OH now owns 9,575 shares of the exchange traded fund’s stock valued at $946,000 after purchasing an additional 3,720 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $99.31 on Wednesday. The stock has a market cap of $7.57 billion, a PE ratio of 11.47 and a beta of 1.11. The business’s fifty day moving average is $98.75 and its 200-day moving average is $94.23. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.